Improving Tolerance of Treatment of Pulmonary Mycobacterium Avium Complex Infections
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Ondansetron (Primary)
- Indications Nausea and vomiting
- Focus Therapeutic Use
- 01 Mar 2013 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 17 Jan 2013 Planned end date changed from 1 Dec 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
- 01 Jan 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.